Patient characteristic | N | RR (95% CI) | p value |
---|---|---|---|
Gender | 106 | Â | Â |
 Male | 79 | 1 |  |
 Female | 27 | 0.543 (0.309–0.956) | 0.034* |
T classification | 106 | Â | Â |
 T1+T2 | 22 | 1 |  |
 T3+T4 | 84 | 1.817 (0.937–3.525) | 0.077 |
N classification | 106 | Â | Â |
 N0+N1 | 83 | 1 |  |
 N2+N3 | 23 | 1.492 (0.850–2.618) | 0.163 |
Clinical stage | 106 | Â | Â |
 I–II | 52 | 1 |  |
 III–IV | 54 | 1.915 (1.088–3.370) | 0.024* |
HPSE expression | 106 | Â | Â |
 Low | 88 | 1 |  |
 High | 18 | 0.727 (0.375–1.412) | 0.347 |